Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VISX -- Ignore unavailable to you. Want to Upgrade?

To: Chuzzlewit who wrote (1395)	11/21/1999 7:53:00 PM
From: Jack Jackson	Read Replies (1) \| Respond to of 1754

VISX says FDA approves laser for nearsightedness November 21, 1999 03:32 PM Eastern Time NEW YORK, Nov 21 (Reuters) - Refractive laser technology company VISX Inc. VISX said the U.S. Food and Drug Administration approved its laser system for the treatment of nearsightedness and astigmatism. The VISX STAR S2 Excimer Laser System can be used for up to 14 diopters of myopia, or nearsightedness, with up to 5 diopters of astigmatism, the company said. Shares in the Santa Clara, Calif.-based VISX closed 4-1/4 points lower on Friday, at 79-1/16. The FDA approval was announced after the markets closed. ((Amy Collins, New York Newsdesk +212 859 1700)) REUTERS